Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter L Anderson

Showing results (181-190 of 271) with videos related to

Pageof 28
Sort By:
AIDS and Behavior|February 25, 2019
Engagement in Mental Health Care is Associated with Higher Cumulative Drug Exposure and Adherence to Antiretroviral TherapyRyan P Coyle, Christopher D Schneck, Mary Morrow, et al.
AIDS (London, England)|March 22, 2024
Concordance between daily diary reported pre-exposure prophylaxis intake and intraerythrocytic tenofovir diphosphate in the Amsterdam Pre-exposure Prophylaxis demonstration projectEline S Wijstma, Vita W Jongen, Anders Boyd, et al.
AIDS Care|March 22, 2019
Effective use of pre-exposure prophylaxis (PrEP) Among stimulant users with multiple condomless sex partners: a longitudinal study of men who have sex with men in Los AngelesDavid Goodman-Meza, Matthew R Beymer, Ryan M Kofron, et al.
Open Forum Infectious Diseases|January 15, 2021
Adherence to Direct-Acting Antiviral Therapy in People Actively Using Drugs and Alcohol: The INCLUD StudyKristina M Brooks, Jose R Castillo-Mancilla, Mary Morrow, et al.
Pharmacotherapy|February 17, 2021
Higher medication complexity in persons with HIV is associated with lower tenofovir diphosphate in dried blood spotsAustin M Saderup, Mary Morrow, Anne M Libby, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 10, 2017
Changes in Kidney Function Associated With Daily Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Preexposure Prophylaxis Use in the United States Demonstration ProjectEric C Tang, Eric Vittinghoff, Peter L Anderson, et al.
Open Forum Infectious Diseases|July 21, 2021
Lower Urine Tenofovir Concentrations Among Individuals Taking Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate: Implications for Point-of-Care TestingKelly A Johnson, Xin Niu, David V Glidden, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 23, 2016
Symptoms, Side Effects and Adherence in the iPrEx Open-Label ExtensionDavid V Glidden, K Rivet Amico, Albert Y Liu, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 11, 2022
Understanding Pre-Exposure Prophylaxis Adherence in Young Women in KenyaJessica E Haberer, Nelly Mugo, Elizabeth Ann Bukusi, et al.
Journal of the International AIDS Society|May 11, 2021
Adherence to event-driven HIV PrEP among men who have sex with men in Amsterdam, the Netherlands: analysis based on online diary data, 3-monthly questionnaires and intracellular TFV-DPVita W Jongen, Elske Hoornenborg, Mark Am van den Elshout, et al.
Pageof 28

Showing results (181-190 of 271) with videos related to

Sort By:
Pageof 28
AIDS and Behavior|February 25, 2019
Engagement in Mental Health Care is Associated with Higher Cumulative Drug Exposure and Adherence to Antiretroviral TherapyRyan P Coyle, Christopher D Schneck, Mary Morrow, et al.
AIDS (London, England)|March 22, 2024
Concordance between daily diary reported pre-exposure prophylaxis intake and intraerythrocytic tenofovir diphosphate in the Amsterdam Pre-exposure Prophylaxis demonstration projectEline S Wijstma, Vita W Jongen, Anders Boyd, et al.
AIDS Care|March 22, 2019
Effective use of pre-exposure prophylaxis (PrEP) Among stimulant users with multiple condomless sex partners: a longitudinal study of men who have sex with men in Los AngelesDavid Goodman-Meza, Matthew R Beymer, Ryan M Kofron, et al.
Open Forum Infectious Diseases|January 15, 2021
Adherence to Direct-Acting Antiviral Therapy in People Actively Using Drugs and Alcohol: The INCLUD StudyKristina M Brooks, Jose R Castillo-Mancilla, Mary Morrow, et al.
Pharmacotherapy|February 17, 2021
Higher medication complexity in persons with HIV is associated with lower tenofovir diphosphate in dried blood spotsAustin M Saderup, Mary Morrow, Anne M Libby, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 10, 2017
Changes in Kidney Function Associated With Daily Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Preexposure Prophylaxis Use in the United States Demonstration ProjectEric C Tang, Eric Vittinghoff, Peter L Anderson, et al.
Open Forum Infectious Diseases|July 21, 2021
Lower Urine Tenofovir Concentrations Among Individuals Taking Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate: Implications for Point-of-Care TestingKelly A Johnson, Xin Niu, David V Glidden, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 23, 2016
Symptoms, Side Effects and Adherence in the iPrEx Open-Label ExtensionDavid V Glidden, K Rivet Amico, Albert Y Liu, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 11, 2022
Understanding Pre-Exposure Prophylaxis Adherence in Young Women in KenyaJessica E Haberer, Nelly Mugo, Elizabeth Ann Bukusi, et al.
Journal of the International AIDS Society|May 11, 2021
Adherence to event-driven HIV PrEP among men who have sex with men in Amsterdam, the Netherlands: analysis based on online diary data, 3-monthly questionnaires and intracellular TFV-DPVita W Jongen, Elske Hoornenborg, Mark Am van den Elshout, et al.
Pageof 28